KVUE - Kenvue Inc.

At Kenvue, we are dedicated to realizing the extraordinary power of everyday care, emerging as the world's largest pure-play consumer health company with $15.4 billion in net sales as of 2023. Our business model centers around delivering science-backed, innovative products and holistic consumer health solutions. We operate through three main segments: Self Care, Skin Health and Beauty, and Essential Health, providing an extensive array of trusted brands like Tylenol®, Neutrogena®, and Listerine®, with a presence in over 165 countries and a portfolio that enhances consumer confidence and engagement in health management.

Following our separation from Johnson & Johnson in 2023, we leveraged our robust portfolio and significant global scale to create targeted marketing strategies that cater to the unique needs of each market. Our focus on R&D, utilizing a skilled workforce and deep consumer insights, allows us to innovate effectively while our established distribution networks enhance resilience and agility. With a commitment to Environmental, Social, and Governance (ESG) initiatives, we aim to create long-term value for our stakeholders while maintaining high-quality standards in product offerings.